(1R,4R,5R)-4,5-Dihydroxy-1-(4-hydroxymethyl-benzyloxy)-cyclohex-2-enecarboxylic acid

ID: ALA157279

PubChem CID: 11277824

Max Phase: Preclinical

Molecular Formula: C15H18O6

Molecular Weight: 294.30

Molecule Type: Small molecule

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  O=C(O)[C@]1(OCc2ccc(CO)cc2)C=C[C@@H](O)[C@H](O)C1

Standard InChI:  InChI=1S/C15H18O6/c16-8-10-1-3-11(4-2-10)9-21-15(14(19)20)6-5-12(17)13(18)7-15/h1-6,12-13,16-18H,7-9H2,(H,19,20)/t12-,13-,15+/m1/s1

Standard InChI Key:  JCEAOAIRAVBCET-NFAWXSAZSA-N

Molfile:  

     RDKit          2D

 21 22  0  0  1  0  0  0  0  0999 V2000
    1.7917   -1.5625    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5042   -1.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0875   -1.9792    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.3792   -0.9750    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0875   -2.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.5042   -2.8042    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0792   -1.1500    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    1.7917   -3.2125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1542   -0.1750    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    3.1750   -1.1792    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.3625   -1.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3500   -1.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.2250   -3.2167    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7833   -0.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7917   -4.0375    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0708   -1.5542    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3583   -0.3125    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7833   -1.1417    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0708    0.1000    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5000    0.9208    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -2.5000    0.0958    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  1  0
  3  1  1  0
  1  4  1  1
  5  3  2  0
  6  2  1  0
  1  7  1  6
  8  5  1  0
  9  4  2  0
 10  4  1  0
 11  7  1  0
 12 11  1  0
  6 13  1  1
 14 19  1  0
  8 15  1  6
 16 12  2  0
 17 12  1  0
 18 16  1  0
 19 17  2  0
 20 21  1  0
 21 14  1  0
  8  6  1  0
 14 18  2  0
M  END

Associated Targets(non-human)

aroQ 3-dehydroquinate dehydratase (29 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 294.30Molecular Weight (Monoisotopic): 294.1103AlogP: 0.20#Rotatable Bonds: 5
Polar Surface Area: 107.22Molecular Species: ACIDHBA: 5HBD: 4
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 4#RO5 Violations (Lipinski):
CX Acidic pKa: 3.57CX Basic pKa: CX LogP: 0.00CX LogD: -3.35
Aromatic Rings: 1Heavy Atoms: 21QED Weighted: 0.58Np Likeness Score: 1.38

References

1. González-Bello C, Lence E, Toscano MD, Castedo L, Coggins JR, Abell C..  (2003)  Parallel solid-phase synthesis and evaluation of inhibitors of Streptomyces coelicolor type II dehydroquinase.,  46  (26): [PMID:14667226] [10.1021/jm030987q]

Source